does tirzepatide cause gastritis How to treat symptoms? | In-Home Medical Services Can You Drink Alcohol While

Certifications: Vegan, Non-GMO, and third-party testing documentation

This initial phase is vital for acclimation

How Supplied / Storage and Handling 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1How Supplied MOUNJARO is a clear, colorless to slightly yellow solution available in cartons containing 4 pre-filled single-dose pens, 1 single-dose vial, 1 multi-dose vial, or 1 Single-Patient-Use KwikPen as follows: Single-Dose Vial and Prefilled Pen Strength 4-pack Single-dose Pen NDC 1-pack Single-dose Vial NDC 2.5 mg/0.5 mL 0002-1506-80 0002-1152-01 5 mg/0.5 mL 0002-1495-80 0002-1243-01 7.5 mg/0.5 mL 0002-1484-80 0002-2214-01 10 mg/0.5 mL 0002-1471-80 0002-2340-01 12.5 mg/0.5 mL 0002-1460-80 0002-2423-01 15 mg/0.5 mL 0002-1457-80 0002-3002-01 Multi-Dose Vial Doses per Vial Strength 1-pack Multi-dose Vial NDC 4 doses of 2.5 mg/0.6 mL 10 mg/2.4 mL (4.17 mg/mL) 0002-4052-11 4 doses of 5 mg/0.6 mL 20 mg/2.4 mL (8.33 mg/mL) 0002-4103-11 4 doses of 7.5 mg/0.6 mL 30 mg/2.4 mL (12.5 mg/mL) 0002-4210-11 4 doses of 10 mg/0.6 mL 40 mg/2.4 mL (16.7 mg/mL) 0002-4304-11 4 doses of 12.5 mg/0.6 mL 50 mg/2.4 mL (20.8 mg/mL) 0002-4523-11 4 doses of 15 mg/0.6 mL 60 mg/2.4 mL (25 mg/mL) 0002-4612-11 Single-Patient-Use KwikPen (with four weekly doses) Doses per KwikPen Strength 1-pack Single-Patient-Use KwikPen NDC 4 doses of 2.5 mg 10 mg/2.4 mL (4.17 mg/mL) 0002-3466-11 4 doses of 5 mg 20 mg/2.4 mL (8.33 mg/mL) 0002-3455-11 4 doses of 7.5 mg 30 mg/2.4 mL (12.5 mg/mL) 0002-3444-11 4 doses of 10 mg 40 mg/2.4 mL (16.7 mg/mL) 0002-3433-11 4 doses of 12.5 mg 50 mg/2.4 mL (20.8 mg/mL) 0002-3422-11 4 doses of 15 mg 60 mg/2.4 mL (25 mg/mL) 0002-3411-11 16.2Storage and Handling Do not freeze MOUNJARO

It may be considered for eligible patients after provider review and when clinically appropriate

& Rebecca, V